Diagnosis of neuropsychiatry disorder in patients with anti-MDA5 antibody dermatomyositis: A case report

Heliyon. 2023 Nov 28;9(12):e22935. doi: 10.1016/j.heliyon.2023.e22935. eCollection 2023 Dec.

Abstract

Anti-melanoma differentiation-associated gene 5 (MDA5) dermatomyositis (DM) is a rare disease that can be easily misdiagnosed. Anti-MDA5 dermatomyositis is a subtype of DM. It is distinguished by the presence of significant mucocutaneous characteristics, palmar papules, panniculitis, interstitial lung disease (ILD), and clinically amyopathic dermatomyositis (CADM). When combined with rapidly progressing ILD (RP-ILD), anti-MDA5 DM can be fatal. The literature indicates that nervous system involvement is uncommon in patients with anti-MDA5 DM. We report a case of anti-MDA5 DM with neuropsychiatric abnormalities and ILD. The patient suffered from persistent worsening mental disorders, while his ILD was relatively stable. The patient's neuropsychiatric abnormalities gradually subsided after receiving treatment with glucocorticoids, immunoglobulins, and immunosuppressants, leaving only a slow response and memory loss.

Keywords: Anti-melanoma differentiation-associated gene 5 dermatomyositis; Autoimmune disease; Gottron papules; Neuropsychiatric disorder; Tacrolimus.

Publication types

  • Case Reports